Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
7.29
-0.11 (-1.49%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $450.03 million as of October 16, 2026. It is the 15,420th most valuable company in the world and the 2,806th biggest in the United States. Its market cap has decreased by 59.74% in one year.
Market Cap
450.03M
Enterprise Value
170.59M
1-Year Change
-59.74%
Global Rank
Country Rank
#2,806 United States
Category
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $450.03M, an increase of 182.92%. That is a compound annual growth rate of 21.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 450.03M | -61.02% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 470.87M |
| Arvinas | 462.28M |
| REGENXBIO | 457.47M |
| Allogene Therapeutics | 454.32M |
| BlossomHill Therapeutics | 446.58M |
| Altimmune | 445.45M |
| Autolus Therapeutics | 444.49M |
| YD Bio | 441.28M |